SuperGen Withdraws Drug Application
8921
SuperGen Inc. SUPG.O on Monday said  it has withdrawn an application to market its pancreatic cancer  drug in the United States, casting a cloud on the drug's future  in the world's biggest market and sending the company's shares  down as much as 16 percent.
235785
The World Health Organization (WHO) said on Tuesday that Indian drug maker Ranbaxy had voluntarily withdrawn all of its antiretroviral AIDS drugs from the UN health agency&#39;s approved list.
269056
The Swiss pharmaceuticals regulator said Thursday it ordered the withdrawal of Novartis AG's Zelmac for irritable bowel syndrome, saying the risks of the treatment are greater than the benefit.
228288
The campaign to get cheap Aids drugs to millions of Africans was dealt a blow yesterday when a manufacturer in India admitted it could not prove the quality of its medicines and withdrew them from the list approved by the World Health Organisation.
736697
Ranbaxy Laboratories, India&#39;s biggest pharmaceuticals company, has ended its partnership with a clinical research organisation whose data for Ranbaxyâs generic anti-Aids drugs raised doubts about the authenticity of the medicines.
737400
New Delhi: India&#39;s top drugmaker Ranbaxy Laboratories has voluntarily withdrawn all its antiretroviral AIDS drugs from the UN health agency&#39;s approved list, setting minimum quality standards for cheaper anti-AIDS medication aimed at poor countries, the
290376
A popular painkiller is being withdrawn from the market over concerns about links with overdoses.
533556
Shares of SuperGen Inc. SUPG.O  dropped 17 percent before the bell on Monday after the company  said it withdrew an application to market its pancreatic cancer  treatment in the United States due to insufficient data.
27933
Amgen Inc.'s  multibillion-dollar anemia drug Aranesp is facing further safety concerns after a medical newsletter reported on Friday that a Danish study of the drug in head and neck cancer was halted due to adverse outcomes seen in patients taking part.
442644
AstraZeneca Plc has withdrawn its marketing application for lung cancer pill Iressa in Europe after the drug failed to help patients live longer in a clinical study, Europe's third largest drugmaker said on Tuesday.
48213
Sanofi-Aventis said on Friday it was withdrawing its application to sell obesity drug rimonabant -- its biggest new drug hope -- in the United States.
39231
Shares of SuperGen Inc. SUPG.O  jumped more than 24 percent in trading before the market opened  on Wednesday after MGI Pharma Inc. MOGN.O said it would take  a $40 million stake in the company as part of a cancer drug  license deal.
114882
Under pressure for more data on the long-term safety effects of its Intrinsa testosterone patch, Procter &amp; Gamble Co. has withdrawn its application to the US Food and Drug Administration to market the patch.
439981
THE Ministry of Health yesterday urged Jamaicans to immediately discontinue the use of the arthritis drug Vioxx (refecoxib), which was pulled off the market yesterday by its manufacturer Merck &amp; Co.
451724
Cellegy Pharmaceuticals Inc. (Nasdaq: CLGY) of South San Francisco saw its shares lose about half their value Monday after the US Food and Drug Administration rejected the company&#39;s nitroglycerine ointment for treating pain from chronic anal fissure.
749737
American biotechnology firm Amgen yesterday lost its right to produce a billion-dollar anaemia drug, Epogen, exclusively in the UK after a House of Lords ruling.
332433
Merck&#39;s (MRK :NYSE - news - research) decision to withdraw its popular arthritis drug Vioxx from the market in late September has raised questions about the process leading up to its regulatory approval in 1999 as well as the importance of subsequent